2026 Global: Cell Lysis/Cell Fractionation Market-Competitive Review (2032) report
Description
The 2026 Global: Cell Lysis/Cell Fractionation Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell lysis/cell fractionation market by geography and historical trend. The scope of the report extends to sizing of the cell lysis/cell fractionation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific, Merck KGaA, and Bio‑Rad Laboratories are among the largest suppliers of cell lysis and cell fractionation products, offering broad portfolios that span instruments, reagents, and consumables for protein and nucleic acid extraction as well as organelle isolation; Thermo Fisher’s comprehensive life‑science offerings and global distribution contribute to its leading market presence while Merck (MilliporeSigma in some regions) and Bio‑Rad provide established reagent lines and specialized equipment that serve academic, clinical, and industrial customers. Qiagen, Agilent Technologies, and Promega Corporation supply complementary technologies—Qiagen with nucleic‑acid extraction kits and sample prep workflows, Agilent with analytical and separation instruments that integrate with fractionation workflows, and Promega with enzyme and assay reagents used downstream of lysis—positioning them as key players across molecular biology and proteomics applications. Takara Bio, Abcam, and PerkinElmer deliver targeted reagent families, antibodies, and detection platforms that support isolation and characterization of intracellular components, with Takara notable for molecular biology kits and PerkinElmer for integrated detection and analytics that enhance fractionation-based studies.
Lonza, Sartorius, Danaher (including affiliate brands), and Eppendorf are significant in the instrument and bioprocess segments, supplying homogenizers, cell disruption systems, filtration and separation technologies, and lab automation that scale from research to production; Lonza and Sartorius also serve biopharma process development where robust cell disruption and fractionation are critical, while Danaher’s portfolio (through brands across life‑science tools) and Eppendorf’s benchtop hardware are widely used in academic and industrial labs. Corning and Miltenyi Biotec contribute specialized consumables and cell separation/fractionation solutions—Corning with plates, flasks, and separation consumables that support sample handling and Miltenyi with magnetic cell separation and microbead‑based fractionation tools that enable selective isolation of cell populations and organelles—making them important niche players within the broader market. Other influential companies cited across market reports, such as Beckman Coulter, Becton Dickinson, Roche, Qsonica, Covaris and smaller specialized vendors, further diversify the competitive landscape by offering sonicators, acoustic shearing devices, centrifuges, and high‑pressure systems used specifically for particular cell types or scale requirements.
Market research reports consistently rank these firms based on product breadth, geographic reach, and presence in both instruments and reagents, with North America and Europe representing leading regional markets due to strong research infrastructure and biopharma activity while Asia‑Pacific shows rapid growth driven by expanding R&D investment; reported market valuations and forecasts vary by source but indicate a multi‑billion dollar market with mid‑single‑digit to high single‑digit CAGR projections as demand for proteomics, genomics, and cell‑based therapeutics grows and as vendors continue to introduce integrated workflows and higher‑throughput solutions.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cell lysis/cell fractionation market by geography and historical trend. The scope of the report extends to sizing of the cell lysis/cell fractionation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Thermo Fisher Scientific, Merck KGaA, and Bio‑Rad Laboratories are among the largest suppliers of cell lysis and cell fractionation products, offering broad portfolios that span instruments, reagents, and consumables for protein and nucleic acid extraction as well as organelle isolation; Thermo Fisher’s comprehensive life‑science offerings and global distribution contribute to its leading market presence while Merck (MilliporeSigma in some regions) and Bio‑Rad provide established reagent lines and specialized equipment that serve academic, clinical, and industrial customers. Qiagen, Agilent Technologies, and Promega Corporation supply complementary technologies—Qiagen with nucleic‑acid extraction kits and sample prep workflows, Agilent with analytical and separation instruments that integrate with fractionation workflows, and Promega with enzyme and assay reagents used downstream of lysis—positioning them as key players across molecular biology and proteomics applications. Takara Bio, Abcam, and PerkinElmer deliver targeted reagent families, antibodies, and detection platforms that support isolation and characterization of intracellular components, with Takara notable for molecular biology kits and PerkinElmer for integrated detection and analytics that enhance fractionation-based studies.
Lonza, Sartorius, Danaher (including affiliate brands), and Eppendorf are significant in the instrument and bioprocess segments, supplying homogenizers, cell disruption systems, filtration and separation technologies, and lab automation that scale from research to production; Lonza and Sartorius also serve biopharma process development where robust cell disruption and fractionation are critical, while Danaher’s portfolio (through brands across life‑science tools) and Eppendorf’s benchtop hardware are widely used in academic and industrial labs. Corning and Miltenyi Biotec contribute specialized consumables and cell separation/fractionation solutions—Corning with plates, flasks, and separation consumables that support sample handling and Miltenyi with magnetic cell separation and microbead‑based fractionation tools that enable selective isolation of cell populations and organelles—making them important niche players within the broader market. Other influential companies cited across market reports, such as Beckman Coulter, Becton Dickinson, Roche, Qsonica, Covaris and smaller specialized vendors, further diversify the competitive landscape by offering sonicators, acoustic shearing devices, centrifuges, and high‑pressure systems used specifically for particular cell types or scale requirements.
Market research reports consistently rank these firms based on product breadth, geographic reach, and presence in both instruments and reagents, with North America and Europe representing leading regional markets due to strong research infrastructure and biopharma activity while Asia‑Pacific shows rapid growth driven by expanding R&D investment; reported market valuations and forecasts vary by source but indicate a multi‑billion dollar market with mid‑single‑digit to high single‑digit CAGR projections as demand for proteomics, genomics, and cell‑based therapeutics grows and as vendors continue to introduce integrated workflows and higher‑throughput solutions.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
